微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 6.71% | -3.31% | 49.78% | 53/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.48% | 2.05% | 89.03% | 41/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.37% | -2.47% | -73.37% | 51/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 8.9% | -22.68% | 28.24% | 35/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 6.94% | -16.39% | 58.09% | 47/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.39% | -14.76% | 80.66% | 50/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.43% | -6.18% | -78.89% | 51/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 11.51% | 13.85% | 38.67% | 34/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.3% | 6% | 61.17% | 43/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.15% | 9.81% | 98.84% | 48/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.59% | 10.68% | -74.38% | 48/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 10.11% | 5.97% | 29.12% | 44/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 7.83% | 0.51% | 66.95% | 55/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.69% | 6.35% | 100.43% | 59/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.34% | 21.88% | -75.47% | 59/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 9.54% | 15.36% | 22.46% | 56/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.79% | 19.66% | 76.64% | 50/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.41% | 2.08% | 129.69% | 63/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.92% | 7.87% | -76.78% | 49/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.27% | 1.97% | 27.04% | 68/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.51% | 3.17% | 50.69% | 54/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.32% | -0.23% | 142.7% | 60/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.78% | -0.56% | -78.05% | 60/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 8.11% | 6.01% | 28.53% | 65/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.31% | 7.13% | 45.73% | 51/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.33% | 3.34% | 141.9% | 48/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.79% | 14.74% | -76.6% | 62/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.65% | -1.42% | 29.88% | 69/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.89% | 2.61% | 40.57% | 55/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.19% | 12.94% | 168.59% | 60/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.56% | -2.5% | -79.9% | 52/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 7.76% | 3.74% | 35.19% | 68/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 5.74% | -5.59% | 54.72% | 48/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 3.71% | -16.44% | 131.88% | 50/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.6% | -38.46% | -78.61% | 49/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 7.48% | -29.7% | 23.03% | 60/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 6.08% | -25.49% | 36.94% | 41/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 4.44% | -18.68% | 70.77% | 41/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.6% | 6.12% | -75.56% | 34/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 10.64% | 14.29% | 30.39% | 48/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 8.16% | 13.33% | 49.45% | 26/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 5.46% | 12.35% | 122.86% | 22/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 2.45% | 31.72% | -73.68% | 26/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |